Kwality Pharmaceuticals receives approval from ANVISA for injectable unit

Kwality Pharmaceuticals Limited has received approval from Brazil's National Health Surveillance Agency ANVISA (Agencia Nacional de Vigilancia Sanitaria) for its Injectable formulations manufacturing unit at Amritsar along with Oncology Injectable Unit at Himachal Pradesh. The approval grants access to the Company to register and market its products at the large and growing Brazilian Pharmaceutical Market.

The ANVISA approved facility is capable to manufacture liquid injection (in form of Ampoule and vials) and lyophilized formulation (vials).

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 369.60 as compared to the previous close of Rs. 362.85. The total number of shares traded during the day was 17072 in over 589 trades.

The stock hit an intraday high of Rs. 380.00 and intraday low of 365.00. The net turnover during the day was Rs. 6392035.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 ANVISA Approval InjectableFormulationsUnit OncologyInjectable HimachalPradesh